home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Structure-Based Drug Design

 
  February 01, 2013  
     
 
The Revere Hotel, 200 Stuart Street
June 19-21, 2013


The 13th Structure-Based Drug Discovery conference will feature the development of in silico technology as well as experimental approaches useful for accurately predicting and modeling the structures of proteins in structure-based drug design efforts. In addition, examples of successful applications of such technology approaches to genome-to-drug lead investigations are showcased.

Topics to be covered may include:

  • Recent research on important targets that are amenable to structure-based drug design, such as GPCRs
  • Design of therapeutic agents that interact with protein-protein interaction hot spots as targets
  • Large-scale informatics framework that integrate functional, structural and expression information for contextual drug discovery
  • Mining the bacterial genome for novel bioactive compounds
  • Epigenetics in drug discovery
  • Cellular environment including solvation in drug discovery
  • Fragment-based design
  • Other interesting topics
Click here for more information.
 
 
Organized by: Cambridge Healthtech Institute
Invited Speakers: For speaker information, please visit our website.
 
Deadline for Abstracts: May 10, 2013
 
Registration: Register Now
E-mail: kwaterman@healthtech.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.